In episode 09 of the PharmSci Today podcast, Paul Bennett (CEO, RPS), Prof Gino Martini (RPS Chief Scientist) and Sarah Cahill (Clinical Fellow, RPS) talk to Richard Saynor(CEO, Sandoz).
Richard discusses Sandoz’s response to COVID-19 and how they are maintaining supply chains and supporting clinical trials to combat the coronavirus. Sandoz is one of the largest suppliers of generic medicines in the world and is separate division of Novartis.
